Eagle Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net Income	11.95	35.64	-8.63	11.99	14.31	31.9
Depreciation & Amortization	21.92	13.27	4.81	4.77	4.65	3.67
Other Amortization	0.46	0.47	0.47	0.42	0.48	0.38
Asset Writedown & Restructuring Costs	-	-	-	-	-	8.47
Loss (Gain) From Sale of Investments	1.42	4.46	6.17	5.3	-	-
Stock-Based Compensation	16.49	16.45	19.56	24.76	22	19.08
Other Operating Activities	-3.92	-3.18	-3.69	1.45	0.15	-3.23
Change in Accounts Receivable	-29.22	-30.83	9.53	-3.11	18.48	-12.67
Change in Inventory	5.1	-8.34	-13.83	-1.51	1.74	-5.56
Change in Accounts Payable	-3.12	2.97	10.16	0.81	-4.46	-2.06
Change in Other Net Operating Assets	-30.4	19.8	3.68	4.63	-1.37	12.4
Operating Cash Flow	-9.32	50.7	28.22	49.5	55.99	52.38
Operating Cash Flow Growth	-	79.67%	-42.99%	-11.59%	6.88%	-11.09%
Capital Expenditures	-0.07	-0.18	-0.32	-0.75	-0.78	-0.13
Cash Acquisitions	1.26	-74.15	-	-	-	-
Investment in Securities	-25	-12.5	-	-17.5	-	-
Other Investing Activities	-	-	-5	-	-	-
Investing Cash Flow	-23.81	-86.83	-5.32	-18.25	-0.78	-0.13
Short-Term Debt Issued	-	30	-	110	-	-
Long-Term Debt Issued	-	50	-	-	-	-
Total Debt Issued	110	80	-	110	-	-
Short-Term Debt Repaid	-	-15	-	-110	-	-
Long-Term Debt Repaid	-	-52.24	-8	-5	-6	-3.75
Total Debt Repaid	-85.74	-67.24	-8	-115	-6	-3.75
Net Debt Issued (Repaid)	24.26	12.76	-8	-5	-6	-3.75
Issuance of Common Stock	0.25	1.75	2.4	3.65	0.26	8.62
Repurchase of Common Stock	-11.23	-19.36	-22.79	-36.52	-18.16	-73.11
Other Financing Activities	-1.36	-1.36	-	-	-0.33	-19.88
Financing Cash Flow	11.92	-6.21	-28.39	-37.87	-24.23	-88.12
Net Cash Flow	-21.21	-42.34	-5.5	-6.62	30.98	-35.87
Free Cash Flow	-9.39	50.52	27.9	48.75	55.21	52.25
Free Cash Flow Growth	-	81.11%	-42.78%	-11.70%	5.66%	-4.10%
Free Cash Flow Margin	-3.65%	15.96%	16.26%	25.96%	28.18%	24.50%
Free Cash Flow Per Share	-0.71	3.87	2.14	3.54	3.90	3.42
Cash Interest Paid	4.06	1.73	1.2	2.22	-	2.08
Cash Income Tax Paid	37.2	28.41	10.01	6.43	6.67	2.28
Levered Free Cash Flow	38.31	87.63	31.68	50.08	54.07	30.32
Unlevered Free Cash Flow	41.66	89.68	32.23	51.27	55.27	31.66
Change in Working Capital	-57.64	-16.4	9.54	0.82	14.39	-7.89

Updated Aug 8, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.